Send us Feedback

Biotechnology

RECENT NEWS
Merck Serono CEO stakes out Boston biotech startups
FierceBiotech  May 24  Comment 
Merck Serono CEO Stephan Oschmann has made overtures to biotech entrepreneurs as the pharma group seeks ways to bolster its business after a series of R&D setbacks such as the failure of an experimental oral drug for multiple sclerosis and major...
Aveo shares shellacked after Astellas drops EU game plan on kidney cancer
FierceBiotech  May 24  Comment 
Three weeks after an FDA panel overwhelmingly rejected Aveo's bid to gain an approval for its kidney cancer drug tivozanib, the biotech has earned another vote of no confidence--this time from its pharma partner.
Biotech Offers Revolutionary Technology
Wealth Daily  May 23  Comment 
Given Imaging's (NASDAQ: GIVN) breakthrough technology could make colon cancer screening as easy as swallowing a pill...
City of Mason and Top Gun Sales Launch One-of-a-Kind Tech Hub
Cloud Computing  May 23  Comment 
The City of Mason and Top Gun Sales Performance jointly announced the opening of the Mason Tech Center, an innovative class A office space created through a partnership between the two entities. The Tech Center, designed to...
A 'rational' market finally develops an appetite for biotech IPOs
FierceBiotech  May 23  Comment 
For 5 long years the IPO window on Wall Street has largely been closed to biotech companies. But with investors warming up to the potential rewards after a lengthy chill, Portola Pharmaceuticals became the latest biotech to pull off a successful...
UPDATED: Cash-strapped biotech fails PhIII test for pioneering Fragile X drug
FierceBiotech  May 23  Comment 
Seaside Therapeutics has revealed its second failed study for its lead drug STX209 this month. In one of two Phase III studies for the compound for the genetic mental disorder Fragile X syndrome, STX209 treatment missed its main goal of reducing...
Could African Crops Be Improved With Private Biotech Data?
NPR  May 22  Comment 
A plant scientist at Mars Inc. has appealed to the world's biggest life sciences companies to help him — by sharing what they already know about 100 crops that could provide better nutrition in Africa. But can the kings of agricultural...
Debunking Myths About Biotech Venture Capital
Forbes  May 22  Comment 
There are lots of myths about venture capital and biotech in particular, as noted previously on this blog.  Many of these myths are deeply held beliefs about returns, what works and what doesn’t, and the state of the industry.  Told often...
Organic Lobby Attacks Biotech Advances, Obscures Own Sustainability And Nutrition Doubletalk
Forbes  May 22  Comment 
As the Genetic Literacy Project reports, the organic industry has a direct commercial interest in sowing confusion and doubt about genetically engineered crops and food ingredients derived from them.




Contents

RELATED WIKI ARTICLES

Related Articles

more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Sr. Director
Helen Han
Sr. Associate
Drugmaroht

Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors




Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share

References

  1. ↑ State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009 http://knol.google.com/k/top-ten-twenty-best-selling-drugs-2009#

M&A Biotechnology http://knol.google.com/k/m-a-biotechnology#

http://knol.google.com/k/biotechnology-market-review-top-ten-biologics-2009#

Monoclonal Antibody Market 2009 http://knol.google.com/k/-/monoclonal-antibody-market-2009/3fy5eowy8suq3/86#

http://knol.google.com/k/new-drug-approvals-usa-fda-2009#

http://knol.google.com/k/new-drug-approvals-europe-ema-2009#

Vaccine Market 2009 http://knol.google.com/k/-/vaccine-market-2009/3fy5eowy8suq3/104#

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs) http://knol.google.com/k/global-monoclonal-antibodies-market-review-2008-world-top-ten-mabs#

M&A Review: Pharmaceutical & Biotechnology Industry http://knol.google.com/k/m-a-review-pharmaceutical-biotechnology-industry#

Global Vaccine Market Review 2008 (World Top Ten Vaccines) http://knol.google.com/k/global-vaccine-market-review-2008-world-top-ten-vaccines#


Ipilimumab (BMS) Review: A Cancer Breakthrough? http://knol.google.com/k/-/ipilimumab-bms-review-a-cancer/3fy5eowy8suq3/107#

Denosumab (Prolia, Amgen) FDA Review & Approval http://knol.google.com/k/-/denosumab-prolia-amgen-fda-review/3fy5eowy8suq3/60#

Retrieved from "http://www.wikinvest.com/industry/Biotechnology"

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki